Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M92.7Revenue $M3,799Net Margin (%)--Altman Z-Score4.7
Enterprise Value $M-10.1EPS $-1.2Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book0.710-y EBITDA Growth Rate %--Quick Ratio12.7Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio12.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-50.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-107.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LIFEMario Gabelli 2014-03-31 Sold Out -0.47%$75.75 - $76.07
($75.91)
$ 3.92-95%Sold Out0
LIFEJohn Paulson 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.92-95%Sold Out0
LIFEJoel Greenblatt 2014-03-31 Sold Out -0.03%$75.75 - $76.07
($75.91)
$ 3.92-95%Sold Out0
LIFEFirst Eagle Investment 2014-03-31 Sold Out -0.02%$75.75 - $76.07
($75.91)
$ 3.92-95%Sold Out0
LIFEJohn Paulson 2013-12-31 Reduce-0.04%$74.72 - $75.78
($75.43)
$ 3.92-95%Reduce -50.48%89,657
LIFEFirst Eagle Investment 2013-12-31 Reduce-0.03%$74.72 - $75.78
($75.43)
$ 3.92-95%Reduce -63.70%72,600
LIFEJoel Greenblatt 2013-12-31 Add0.02%$74.72 - $75.78
($75.43)
$ 3.92-95%Add 320.36%14,885
LIFEJohn Paulson 2013-09-30 Reduce-0.58%$74.06 - $74.96
($74.61)
$ 3.92-95%Reduce -85.90%181,053
LIFEFirst Eagle Investment 2013-09-30 Reduce-0.06%$74.06 - $74.96
($74.61)
$ 3.92-95%Reduce -56.11%200,000
LIFEJoel Greenblatt 2013-09-30 Reduce-0.02%$74.06 - $74.96
($74.61)
$ 3.92-95%Reduce -67.32%3,541
LIFEJohn Paulson 2013-06-30 Reduce-4.93%$64.57 - $74.41
($72.6)
$ 3.92-95%Reduce -91.31%1,284,433
LIFEJohn Rogers 2013-06-30 Sold Out -1.9%$64.57 - $74.41
($72.6)
$ 3.92-95%Sold Out0
LIFERobert Olstein 2013-06-30 Sold Out -1.1%$64.57 - $74.41
($72.6)
$ 3.92-95%Sold Out0
LIFEMeridian Funds 2013-06-30 Sold Out -0.83%$64.57 - $74.41
($72.6)
$ 3.92-95%Sold Out0
LIFERonald Muhlenkamp 2013-06-30 Sold Out -0.67%$64.57 - $74.41
($72.6)
$ 3.92-95%Sold Out0
LIFEMario Gabelli 2013-06-30 Add0.59%$64.57 - $74.41
($72.6)
$ 3.92-95%Add 3187.35%1,311,520
LIFEFirst Eagle Investment 2013-06-30 Buy 0.1%$64.57 - $74.41
($72.6)
$ 3.92-95%New holding455,735
LIFEJoel Greenblatt 2013-06-30 Reduce-0.02%$64.57 - $74.41
($72.6)
$ 3.92-95%Reduce -33.08%10,836
LIFERonald Muhlenkamp 2013-03-31 Reduce-1.77%$49.03 - $65.27
($60.09)
$ 3.92-93%Reduce -76.85%50,000
LIFERobert Olstein 2013-03-31 Reduce-0.62%$49.03 - $65.27
($60.09)
$ 3.92-93%Reduce -38.51%99,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LIFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Flynn James E 2015-05-12Buy50,000$14-72view
AKKARAJU SRINIVASFormer 10% Owner 2015-05-12Buy320,000$14-72view
Sofinnova Venture Partners IX,10% Owner 2015-05-12Buy320,000$14-72view
UPRICHARD DAVID CDirector 2013-05-29Sell2,010$74.04-94.71view
COTTINGHAM JOHN AChief Legal Officer 2013-05-28Sell60,000$74.03-94.7view
LORIMIER BRADLEY GDirector 2012-12-11Sell20,000$51.06-92.32view
GRIMM DONALD WDirector 2012-11-20Sell12,052$47.94-91.82view
RICHARD KELLIChief Accounting Officer 2012-11-06Sell6,194$49.19-92.03view
LEVINE ARNOLD JDirector 2012-10-15Sell6,958$48.52-91.92view
LUCIER GREGORY TCEO 2012-09-18Sell169,868$50-92.16view

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com
No related article found.

More From Other Websites
ATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jan 29 2016
CryoLife Completes Acquisition of On-X Life Technologies Holdings, Inc. Jan 20 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jan 11 2016
aTyr Provides Corporate Update And Outlook For 2016 Jan 11 2016
aTyr Provides Corporate Update And Outlook For 2016 Jan 11 2016
aTyr Pharma to Present at 34th Annual J.P. Morgan Healthcare Conference Jan 07 2016
aTyr Pharma to Present at 34th Annual J.P. Morgan Healthcare Conference Jan 07 2016
aTyr Pharma Appoints Sanuj Ravindran, M.D., as Chief Business Officer Jan 06 2016
aTyr Pharma Appoints Sanuj Ravindran, M.D., as Chief Business Officer Jan 06 2016
ATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 28 2015
aTyr Pharma (LIFE) Jumps: Stock Moves 18.8% Higher Dec 18 2015
aTyr Pharma Added to NASDAQ Biotechnology Index Dec 16 2015
aTyr Pharma Added to NASDAQ Biotechnology Index Dec 16 2015
aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine for GMP Process... Dec 09 2015
aTyr Pharma to Host Breakout Session at the 6th Annual World Orphan Drug Congress Dec 09 2015
aTyr Pharma Announces Third Quarter 2015 Operating Results Dec 09 2015
Is aTyr Pharma Inc (LIFE) A Good Stock To Buy? Dec 09 2015
aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine for GMP Process... Nov 11 2015
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 10 2015
aTyr Pharma Announces Third Quarter 2015 Operating Results Nov 10 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK